Valuation: RAMM Pharma Corp.

Market Cap 11.94L 8L 7L 7L 6L 8.11Cr 12.14L 81.95L 32.06L 4.01Cr 31.78L 31.09L 14Cr P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 5L 3L 3L 3L 3L 3.2Cr 5L 32.29L 12.63L 1.58Cr 12.52L 12.25L 5.46Cr EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 month-33.33%
3 months-33.33%
6 months-71.43%
Current year-83.33%
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.8
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap.
02/06/25 Sell

Chief Executive Officer

46,67,000 3.9091%
21/03/25 Buy

Chief Executive Officer

2,00,000 0.1675%
21/03/25 Buy

Chief Executive Officer

1,00,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-83.33% 8L
+1.93%+6.43%+50.20%+168.28% 1,06800Cr
+0.29%+7.20%+58.48%+53.57% 64TCr
+2.45%+3.88%+38.32%+76.82% 45TCr
+2.17%+10.91%+41.94%+35.03% 35TCr
+1.46%+5.93%+40.44%+43.69% 30TCr
+0.40%+4.52%+19.79%+20.93% 27TCr
+2.73%+2.26%-25.81%-36.98% 22TCr
+4.48%+7.94%+28.22%+66.53% 20TCr
+2.91%+0.83%+15.59%+75.56% 16TCr
Average +1.49%+2.48%+26.72%+42.01% 36.63TCr
Weighted average by Cap. +0.99%+2.85%+39.07%+81.20%

Financials

2024 2025
Net sales 43.42L 30.76L 27.04L 25.21L 23.18L 29Cr 44.14L 2.98Cr 1.17Cr 15Cr 1.16Cr 1.13Cr 50Cr 33.61L 23.81L 20.93L 19.51L 17.94L 23Cr 34.17L 2.31Cr 90.24L 11Cr 89.46L 87.52L 39Cr
Net income -1.65Cr -1.17Cr -1.03Cr -95.81L -88.09L -112.09Cr -1.68Cr -11Cr -4.43Cr -55Cr -4.39Cr -4.3Cr -191.62Cr -89.1L -63.13L -55.49L -51.73L -47.56L -61Cr -90.59L -6.12Cr -2.39Cr -30Cr -2.37Cr -2.32Cr -103.46Cr
Net Debt -6L -4L -4L -4L -3L -4.25Cr -6L -42.95L -16.8L -2.1Cr -16.66L -16.3L -7.27Cr -7L -5L -5L -4L -4L -4.91Cr -7L -49.66L -19.43L -2.43Cr -19.26L -18.84L -8.4Cr
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. RAMM Stock